Does 5-Amino-1MQ Need to Be Refrigerated? (Half-Life)

Most vials that lose potency never die on a warm shelf. They die from moisture ingress and repeated freeze-thaw cycling, which is a completely different failure mode, and 5-Amino-1MQ (5-amino-1-methylquinolinium, a small quaternary ammonium salt with a cation mass of roughly 159 g/mol) is considerably more robust against ambient heat than the fragile peptides sitting beside it in the same fridge.

Our team fields handling questions from research buyers every week, and almost all of them collapse into a single confusion. Someone reads a 5 amino 1mq half life figure on a forum, assumes it describes how long the material survives in a vial, and then sets a storage policy based on a number that was never about storage at all.

Does 5-Amino-1MQ need to be refrigerated?

Sealed, desiccated lyophilised 5-Amino-1MQ powder does not require refrigeration for short-term handling and tolerates ambient transit temperatures. For long-term storage, keep it at -20C or colder, protected from light and moisture. Once dissolved in solvent, hold the solution at 2-8C, shield it from light, and treat it as a short working preparation.

Here's what a storage label never tells you. The 5 amino 1mq half life quoted across message boards is a plasma elimination figure drawn from rodent pharmacology, not a vial stability rating, and the two clocks run independently of each other: one is measured in hours inside a living system, the other in months or years inside a freezer. What follows covers stability by storage state, what published work on NNMT inhibitors actually measured, and why the timing searches people run have no literature answer worth quoting.

Cold chain, ambient transit and what actually degrades the vial

The degradation risks for 5-Amino-1MQ rank in a specific order, and temperature isn't at the top of it. Moisture is. Lyophilised powder is hygroscopic by design, so a vial that has been opened, left unsealed, or cycled in and out of a freezer accumulates condensation on every warm-up. That water doesn't just dilute the contents. It creates a hydrated micro-environment where the powder cakes, becomes impossible to weigh reproducibly, and loses the desiccated state that made it archive-stable in the first place.

Light comes second. The quinolinium ring system carries a conjugated chromophore, meaning it absorbs in the near-UV range, and any solution of it left in clear glass under bench lighting is accumulating photodegradation products you cannot see. Amber vials or foil wrapping cost nothing and remove the variable entirely.

Temperature matters most after reconstitution, not before. A sealed powder vial that spent three days at 25C in a delivery van is generally intact. A reconstituted solution left at that same temperature for three days is a different proposition, because now you have a solvated compound plus whatever microbial load the septum picked up.

In our experience, the single most common handling error we see reported is thawing an entire vial to draw a small sample, then refreezing the rest. Equilibrate to room temperature before opening, take what the experiment needs, and log every excursion.

What a half-life number measures, and what it never measures

Half-life describes the time required for plasma concentration of a compound to fall by 50 percent. That's an elimination metric, full stop. It is not a measure of how long a compound's biological effect persists, and with an enzyme inhibitor the gap between those two things can be substantial.

5-Amino-1MQ is a small-molecule inhibitor of NNMT (nicotinamide N-methyltransferase), the enzyme that transfers a methyl group from SAM (S-adenosylmethionine) onto nicotinamide, producing 1-methylnicotinamide and SAH. Nicotinamide that escapes methylation stays available to NAMPT (nicotinamide phosphoribosyltransferase) in the NAD+ salvage pathway. That mechanism was described in work by Neelakantan and colleagues published in Biochemical Pharmacology, which reported that membrane-permeable NNMT inhibitors reversed high-fat-diet-induced obesity in mice, with follow-up work in the same journal examining effects on aged skeletal muscle stem cells.

Here's the insight most write-ups miss entirely. Because the compound competes at an enzyme active site, the downstream consequence, a shift in the nicotinamide and NAD+ substrate pools, does not switch off the moment plasma levels drop. Metabolite pool turnover lags the parent compound. So 'how long does 5 amino 1mq stay in your system' and 'how long does 5 amino 1mq last' are two genuinely different questions with two different answers, and the 5 amino 1mq half life only answers the first one.

The published rodent pharmacokinetics point to rapid clearance measured in hours rather than days. No human pharmacokinetic dataset has been published.

Morning or night: why the timing searches have no literature behind them

There is no published research establishing a best time of day for 5-Amino-1MQ in humans, because there is no published human trial to derive one from. The rodent studies dosed animals by intraperitoneal injection and oral gavage on fixed schedules chosen for experimental control and animal welfare logistics, not for chronobiology. Nobody ran a morning-versus-evening arm.

The same gap explains the 5 amino 1mq half life subq searches. Subcutaneous absorption kinetics for this compound have not been characterised in a published human dataset, so any hour figure attached to that route is extrapolation dressed up as data. NNMT expression does vary meaningfully by tissue, with adipose and liver among the most studied, and NAD+ metabolism broadly shows circadian rhythmicity. Neither of those facts produces a timing recommendation for a specific molecule.

We'll be straightforward about our position here. Real Peptides supplies research-grade compounds to laboratories and researchers. We do not provide administration timing, dosing, or protocol guidance to individuals, because the material is not intended for human or veterinary consumption and because giving that guidance would require clinical data that does not exist. Anyone whose interest stems from a companion animal should talk to their veterinarian rather than extrapolating from mouse adipose tissue studies.

This article is educational and describes laboratory handling and published literature only.

5 Amino 1MQ half life versus vial shelf life: a storage comparison

The 5 amino 1mq half life governs behaviour inside an organism; the table below governs behaviour inside a vial. These are the storage states most labs encounter and what fails first in each.

What If: Vial Handling Scenarios

What if the vial arrived warm after several days in transit?

Log the excursion, then move the sealed powder into cold storage and proceed. Lyophilised 5-Amino-1MQ is a stable small-molecule salt, not a temperature-sensitive protein, and short ambient exposure during shipping is the normal condition this class of compound travels under. The material that genuinely cannot tolerate a warm van is reconstituted solution, which should never be shipped that way in the first place.

What if the reconstituted solution has turned yellow or shows particles?

Discard it and document the batch. Visible colour change in a quinolinium solution suggests photodegradation or oxidation products, and particulate matter points to either precipitation at the working concentration or microbial contamination from a compromised septum. Neither condition can be reversed by filtration, and neither can be assessed for potency without analytical equipment most benches don't have.

What if the powder was frozen, thawed, and refrozen several times?

Treat the vial as compromised for quantitative work. Each cycle deposits condensation onto hygroscopic powder, and the cumulative water uptake changes both the weighing accuracy and the local chemistry inside the vial. Aliquoting at the point of first use, rather than repeatedly opening a single stock vial, eliminates this problem entirely and costs one extra step.

What if the supplier provides no certificate of analysis?

Assume identity and purity are unverified and price the material accordingly. A certificate should report HPLC purity, mass spectrometry identity confirming the expected mass, and the batch number that ties the document to the vial in your hand. Without those, any half-life or stability discussion is theoretical, because you cannot confirm the compound in the vial is the compound on the label.

The uncomfortable truth about clearance numbers online

Let's be direct about this: most of the precise-sounding 5 amino 1mq half life figures circulating online trace back to nothing. No human trial, no cited paper, no primary source. They get copied between product pages and forum posts until repetition manufactures authority. The rodent pharmacology is real and published, and it indicates rapid clearance in hours rather than days. Everything beyond that, particularly route-specific human figures, is extrapolation. A supplier quoting an exact hour value for humans is telling you something about their marketing department, not about pharmacokinetics.

If you're sourcing material for a stability or kinetics study, the documentation matters more than the copy. Our 5-Amino-1MQ listing states the form and purity as supplied, and batch certificates of analysis are published with HPLC purity and mass spectrometry identity so the compound can be verified before it meets a solvent. Researchers building broader panels can work through the full research catalogue or the immune support research collection, and logistics questions are handled through our locations page.

The 5 amino 1mq half life is simultaneously the most searched fact about this compound and the least useful one, because it answers a question about elimination while nearly everyone asking is really wondering about duration of effect. Those are separate clocks. A molecule can be cleared from plasma by lunchtime and still have moved an enzyme's substrate pool for a day afterwards, or clear slowly and accomplish nothing. Until human pharmacokinetics are published, the honest position is that the vial's timeline is well characterised and the body's timeline is not.